New Zealand Joins Australia in Opening Restricted Access to MDMA for PTSD
New Zealand has authorized two psychiatrists to prescribe pharmaceutical-grade MDMA to selected adults with PTSD who have not responded to conventional treatments, while keeping the substance classified as an unapproved medicine. The move creates a tightly controlled access pathway that falls short of broad legalization and places the country somewhere between Australia’s existing model and… Keep Reading
